{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T16:28:08Z","timestamp":1790872088998,"version":"4.1.0"},"reference-count":99,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Circulation"],"published-print":{"date-parts":[[2018,8,21]]},"abstract":"<jats:p>Primary aldosteronism (PA) is the most common form of secondary hypertension. In many cases, somatic mutations in ion channels and pumps within adrenal cells initiate the pathogenesis of PA, and this mechanism might explain why PA is so common and suggests that milder and evolving forms of PA must exist. Compared with primary hypertension, PA causes more end-organ damage and is associated with excess cardiovascular morbidity, including heart failure, stroke, nonfatal myocardial infarction, and atrial fibrillation. Screening is simple and readily available, and targeted therapy improves blood pressure control and mitigates cardiovascular morbidity. Despite these imperatives, screening rates for PA are low, and mineralocorticoid-receptor antagonists are underused for hypertension treatment. After the evidence for the prevalence of PA and its associated cardiovascular morbidity is summarized, a practical approach to PA screening, referral, and management is described. All physicians who treat hypertension should routinely screen appropriate patients for PA.<\/jats:p>","DOI":"10.1161\/circulationaha.118.033597","type":"journal-article","created":{"date-parts":[[2018,9,14]],"date-time":"2018-09-14T03:46:55Z","timestamp":1536896815000},"page":"823-835","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":164,"title":["Primary Aldosteronism"],"prefix":"10.1161","volume":"138","author":[{"given":"James Brian","family":"Byrd","sequence":"first","affiliation":[{"name":"Division of Cardiovascular Medicine (J.B.B.)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adina F.","family":"Turcu","sequence":"additional","affiliation":[{"name":"Division of Metabolism, Endocrinology, and Diabetes (A.F.T., R.J.A.)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.","family":"Auchus","sequence":"additional","affiliation":[{"name":"Division of Metabolism, Endocrinology, and Diabetes (A.F.T., R.J.A.)"},{"name":"Department of Pharmacology (R.J.A.), University of Michigan, Ann Arbor."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.0000040261.30455.b6"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jhh.1001554"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000079505.25750.11"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2017.01.052"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.2147\/IBPC.S13783"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2005.01.015"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2005-0681"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2007.33"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/0895-7061(96)00031-3"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2006.07.059"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-031337"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-4061"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.113.01060"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-2830"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYP.0000000000000066"},{"key":"e_1_3_3_17_2","volume-title":"Sodium-Restricted Diets: The Rationale, Complications, and Practical Aspects of Their Use","author":"National Research Council","year":"1954","unstructured":"National Research Council. Sodium-Restricted Diets: The Rationale, Complications, and Practical Aspects of Their Use. Washington, DC: Division of Biology and Agriculture, National Research Council; 1954."},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1530\/JME-15-0318"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pharmtox-010716-104651"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1210\/en.2013-1834"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1089\/bio.2015.0032"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.1984.247.3.E328"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.52.1.146"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2013.11.022"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ejcn.1600389"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.surg.2012.08.042"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2008-1078737"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-3726"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-4255"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2015.04.022"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1111\/cen.13442"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-2010"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/7834356"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1505529112"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.117.028201"},{"key":"e_1_3_3_36_2","first-page":"1109","article-title":"Hypertension, increased aldosterone secretion and low plasma renin activity relieved by dexamethasone.","volume":"95","author":"Sutherland DJ","year":"1966","unstructured":"Sutherland, DJ, Ruse, JL, Laidlaw, JC. Hypertension, increased aldosterone secretion and low plasma renin activity relieved by dexamethasone. Can Med Assoc J. 1966;95:1109\u20131119.","journal-title":"Can Med Assoc J"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1038\/355262a0"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1681.1991.tb01446.x"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-018-0048-5"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-018-0053-8"},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-0594"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1198785"},{"key":"e_1_3_3_43_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2695"},{"key":"e_1_3_3_44_2","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.06315"},{"key":"e_1_3_3_45_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.113.01733"},{"key":"e_1_3_3_46_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-2885"},{"key":"e_1_3_3_47_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2550"},{"key":"e_1_3_3_48_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2716"},{"key":"e_1_3_3_49_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1504869"},{"key":"e_1_3_3_50_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2005-1309"},{"key":"e_1_3_3_51_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2005-0836"},{"key":"e_1_3_3_52_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.107.100438"},{"key":"e_1_3_3_53_2","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-10-1085"},{"key":"e_1_3_3_54_2","doi-asserted-by":"publisher","DOI":"10.1677\/JOE-07-0037"},{"key":"e_1_3_3_55_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0712000105"},{"key":"e_1_3_3_56_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-2900"},{"key":"e_1_3_3_57_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jash.2008.05.005"},{"key":"e_1_3_3_58_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.116.08952"},{"key":"e_1_3_3_59_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)00257-3"},{"key":"e_1_3_3_60_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.112.197111"},{"key":"e_1_3_3_61_2","doi-asserted-by":"publisher","DOI":"10.3109\/08037059209077510"},{"key":"e_1_3_3_62_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCIMAGING.112.974576"},{"key":"e_1_3_3_63_2","first-page":"212","article-title":"Evidence of exercise-induced myocardial ischemia in patients with primary aldosteronism: the Cross-sectional Primary Aldosteronism and Heart Italian Multicenter Study.","volume":"47","author":"Napoli C","year":"1999","unstructured":"Napoli, C, Di Gregorio, F, Leccese, M, Abete, P, Ambrosio, G, Giusti, R, Casini, A, Ferrara, N, De Matteis, C, Sibilio, G, Donzelli, R, Montemarano, A, Mazzeo, C, Rengo, F, Mansi, L, Liguori, A. Evidence of exercise-induced myocardial ischemia in patients with primary aldosteronism: the Cross-sectional Primary Aldosteronism and Heart Italian Multicenter Study. J Investig Med. 1999;47:212\u2013221.","journal-title":"J Investig Med"},{"key":"e_1_3_3_64_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.67.6.1355"},{"key":"e_1_3_3_65_2","doi-asserted-by":"publisher","DOI":"10.1006\/jmcc.1993.1066"},{"key":"e_1_3_3_66_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199909023411001"},{"key":"e_1_3_3_67_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa030207"},{"key":"e_1_3_3_68_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.31.1.335"},{"key":"e_1_3_3_69_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2005-1733"},{"key":"e_1_3_3_70_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(17)30319-4"},{"key":"e_1_3_3_71_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.281250"},{"key":"e_1_3_3_72_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.125.1.112"},{"key":"e_1_3_3_73_2","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2015.242990"},{"key":"e_1_3_3_74_2","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2011.165662"},{"key":"e_1_3_3_75_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0030-1247545"},{"key":"e_1_3_3_76_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjhyper.2005.01.002"},{"key":"e_1_3_3_77_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0025-6196(11)62105-8"},{"key":"e_1_3_3_78_2","doi-asserted-by":"publisher","DOI":"10.1111\/jch.12523"},{"key":"e_1_3_3_79_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-2788"},{"key":"e_1_3_3_80_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2016-1963"},{"key":"e_1_3_3_81_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(17)30135-3"},{"key":"e_1_3_3_82_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-2803"},{"key":"e_1_3_3_83_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.113.02097"},{"key":"e_1_3_3_84_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jash.2015.04.004"},{"key":"e_1_3_3_85_2","doi-asserted-by":"publisher","DOI":"10.1111\/jch.12570"},{"key":"e_1_3_3_86_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-131-2-199907200-00005"},{"key":"e_1_3_3_87_2","first-page":"CD008169","article-title":"Spironolactone for hypertension.","volume":"8","author":"Batterink J","year":"2010","unstructured":"Batterink, J, Stabler, SN, Tejani, AM, Fowkes, CT. Spironolactone for hypertension. Cochrane Database Syst Rev. 2010;8:CD008169.","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_3_88_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(17)30367-4"},{"key":"e_1_3_3_89_2","doi-asserted-by":"publisher","DOI":"10.1002\/cpt1978244465"},{"key":"e_1_3_3_90_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-032149"},{"key":"e_1_3_3_91_2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008996.pub2"},{"key":"e_1_3_3_92_2","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0000000000001361"},{"key":"e_1_3_3_93_2","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.93136"},{"key":"e_1_3_3_94_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2168.2002.02261.x"},{"key":"e_1_3_3_95_2","doi-asserted-by":"publisher","DOI":"10.7326\/M17-0882"},{"key":"e_1_3_3_96_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.111.169961"},{"key":"e_1_3_3_97_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCOUTCOMES.115.002002"},{"key":"e_1_3_3_98_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.114.04453"},{"key":"e_1_3_3_99_2","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2015.251199"},{"key":"e_1_3_3_100_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.115.06186"}],"container-title":["Circulation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/CIRCULATIONAHA.118.033597","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T08:37:53Z","timestamp":1715589473000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/CIRCULATIONAHA.118.033597"}},"subtitle":["Practical Approach to Diagnosis and Management"],"short-title":[],"issued":{"date-parts":[[2018,8,21]]},"references-count":99,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,8,21]]}},"alternative-id":["10.1161\/CIRCULATIONAHA.118.033597"],"URL":"https:\/\/doi.org\/10.1161\/circulationaha.118.033597","relation":{},"ISSN":["0009-7322","1524-4539"],"issn-type":[{"value":"0009-7322","type":"print"},{"value":"1524-4539","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,21]]},"assertion":[{"value":"2018-08-20","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}